2,6-Difluorobenzaldehyde

We are 2,6-Difluorobenzaldehyde CAS:437-81-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,6-Difluorobenzaldehyde
CAS.NO:437-81-0
Synonyms:2,6-difluoro benzaldehyde;
Molecular Formula:C7H4F2O
Molecular Weight:142.10300
 
Physical and Chemical Properties:
Density:1.317;
Melting point:15-17oC;
Boiling point:82-84oC;
Flash point:73oC;
Index of Refraction:1.502;
 
Specification:
Appearance:Slightly yellow liquid
Purity:≥99.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis

2,6-Difluorobenzaldehyde


Related News: Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.175711-83-8 An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.3-Nitro-N-(2-Hydroxypropyl)-4-Aminophenol CAS:92952-81-3 An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.67-51-6 By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).

Related Products
Product Name
Tosyl Isocyanate View Details
4-chloro-1-benzothiophene View Details
1,2-Ethanedithiol View Details
4-tert-Butylbenzylamine manufacturer ETHYL 2,4-DICHLOROBENZOATE manufacturer 3-Bromophenylboronic acid manufacturer 2-Chloro-3-nitropyridine manufacturer hexamethyldisilazane manufacturer